Aether Bio

Aether Bio leverages a state-of-the-art platform to rapidly engineer enzymes, allowing customers to manufacture complex and novel products at a fraction of the traditional cost. As the first company capable of searching sequence space to discover novel biocatalysts, Aether Bio’s technology can design enzymes for a wide range of chemistries, all within customer timelines. The company’s robotic factory runs millions of experiments to index sequence space, supported by proprietary hardware that enables massively parallelized experimentation. This generates datasets orders of magnitude larger than those of the competition. Aether Bio’s algorithms search through trillions of enzymes, creating a searchable index akin to how Google maps the internet. The company selectively takes on new clients and has raised a Series A funding of $52 million, with backing from investors such as Natural Capital, Unless Partners, Henkel, and Resilience Reserve LLC. Aether Bio is located at 1455 Adams Dr, Suite 1630, Menlo Park, CA 94025.